Evidence map›Paper›PMID 22077904›Full record

ArticlePhotochemistry and photobiology

Miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapy.

Sara B Snell, Thomas H Foster, Constantine G Haidaris

Open access · greenAbstract read
In one paragraph

Article in Photochemistry and photobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Hydralazine potentiates the antiproliferative effect of photodynamic therapy on Candida albicans and Candida parapsilosis in vitro.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Genomic Multiplication and Drug Efflux Influence Ketoconazole Resistance inFrontiers in cellular and infection microbiology · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sara B SnellDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Thomas H Foster
Constantine G Haidaris
University of Rochester Medical Center · US

Funding

Resource in Education in Microbiology and ImmunologyR25GM064133 · NIGMS · UNIVERSITY OF ROCHESTER · PI LORD, EDITH M · 2002 to 2017
$4.2M
PHOTOPHYSICS OF PHOTODYNAMIC THERAPYR01CA068409 · NCI · UNIVERSITY OF ROCHESTER · PI FOSTER, THOMAS HARRISON · 1995 to 2011
$3.8M
NCI NIH HHS CA68409NCI NIH HHS R01 CA068409NIGMS NIH HHS GM064133-2106NIGMS NIH HHS R25 GM064133
6 · The paper itself

Abstract

Cutaneous and mucocutaneous Candida infections are considered to be important targets for antimicrobial photodynamic therapy (PDT). Clinical application of antimicrobial PDT will require strategies that enhance microbial killing while minimizing damage to host tissue. Increasing the sensitivity of infectious agents to PDT will help achieve this goal. Our previous studies demonstrated that raising the level of oxidative stress in Candida by interfering with fungal respiration increased the efficiency of PDT. Therefore, we sought to identify compounds in clinical use that would augment the oxidative stress caused by PDT by contributing to reactive oxygen species (ROS) formation themselves. Based on the ability of the antifungal miconazole to induce ROS in Candida, we tested several azole antifungals for their ability to augment PDT in vitro. Although miconazole and ketoconazole both stimulated ROS production in Candida albicans, only miconazole enhanced the killing of C. albicans and induced prolonged fungistasis in organisms that survived PDT using the porphyrin TMP-1363 and the phenothiazine methylene blue as photosensitizers. The data suggest that miconazole could be used to increase the efficacy of PDT against C. albicans, and its mechanism of action is likely to be multifactorial.

Indexed as

PhotochemotherapyAntifungal AgentsCandida albicansFluconazoleMiconazoleMicrobial Sensitivity TestsOxidative StressPhotosensitizing AgentsPorphyrinsReactive Oxygen SpeciesAntifungal AgentsFluconazoleMiconazolePhotosensitizing AgentsPorphyrinsReactive Oxygen Speciestetra(3-N-methylpyridyl)porphine

Identifiers

PMID22077904
PMCPMC3297714
OpenAlexW1968975986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.